Aspergillus niger fungemia secondary to chronic pulmonary aspergillosis in a patient with invasive squamous cell carcinoma

BMJ Case Rep. 2020 Mar 17;13(3):e234843. doi: 10.1136/bcr-2020-234843.

Authors

Caitlyn Hollingshead¹, Kelly Luttmann¹, Emad Abu Sitta², Hend Elsaghir¹

Affiliations

¹ Infectious Diseases, University of Toledo Medical Center, Toledo, Ohio, USA.
² Infectious Diseases, University of Toledo Medical Center, Toledo, Ohio, USA emademad70@hotmail.com.

No abstract available

Keywords: TB and other respiratory infections; infectious diseases.

Publication types

Case Reports

MeSH terms

Anti-Bacterial Agents / therapeutic use
Antifungal Agents / therapeutic use
Aspergillus niger / drug effects
Carcinoma, Squamous Cell / complications*
Fungemia / drug therapy
Fungemia / microbiology*
Humans
Male
Middle Aged
Piperacillin, Tazobactam Drug Combination / therapeutic use
Pulmonary Aspergillosis / drug therapy
Pulmonary Aspergillosis / microbiology*
Pulmonary Disease, Chronic Obstructive / complications*
Thyroid Neoplasms / complications*
Vancomycin / therapeutic use
Voriconazole / therapeutic use

Substances

Anti-Bacterial Agents
Antifungal Agents
Piperacillin, Tazobactam Drug Combination
Vancomycin
Voriconazole